Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden · Delayed Price · Currency is SEK 8.15
0.00 (0.00%)
Feb 26, 2026, 1:52 PM CET
STO:MAGLE Market Cap
STO:MAGLE has a market cap or net worth of 168.29 million as of February 26, 2026. Its market cap has decreased by -74.33% in one year.
Market Cap
168.29M
Enterprise Value
494.60M
Revenue
300.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.15
Market Cap Chart
Since June 30, 2020, STO:MAGLE's market cap has decreased from 205.10M to 168.29M, a decrease of -17.95%. That is a compound annual growth rate of -3.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 168.29M | -53.69% |
| Dec 30, 2025 | 363.43M | -43.25% |
| Dec 30, 2024 | 640.39M | 135.30% |
| Dec 29, 2023 | 272.16M | -5.97% |
| Dec 30, 2022 | 289.44M | -10.37% |
| Dec 30, 2021 | 322.92M | -29.72% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intervacc AB | 238.57M |
| Sprint Bioscience AB | 234.24M |
| AlzeCure Pharma AB | 224.66M |
| Initiator Pharma | 215.63M |
| Xbrane Biopharma AB | 179.27M |
| NextCell Pharma AB | 170.88M |
| Isofol Medical AB | 165.85M |
| IRLAB Therapeutics AB | 152.89M |